Search filters

List of works by Haidong D. Dong

A T cell equation as a conceptual model of T cell responses for maximizing the efficacy of cancer immunotherapy

scientific article published on 25 February 2017

Apoptosis as a mechanism of lectin-dependent monocyte-mediated cytotoxicity

scientific article published on 01 January 1996

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

scientific article published on 13 July 2009

B7-H1 Influences the Accumulation of Virus-Specific Tissue Resident Memory T Cells in the Central Nervous System.

scientific article published on 9 November 2017

B7-H1 antibodies lose antitumor activity due to activation of p38 MAPK that leads to apoptosis of tumor-reactive CD8(+) T cells

scientific article

B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma ⬇️

scientific article published on October 1, 2003

B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.

scientific article published in March 2004

B7-H1 limits the entry of effector CD8+T cells to the memory pool by upregulating Bim ⬇️

scientific article published on October 1, 2012

B7-H1 pathway and its role in the evasion of tumor immunity.

scientific article

B7-H1 signaling is integrated during CD8(+) T cell priming and restrains effector differentiation

scientific article published on 4 June 2014

B7-h1 expressed by activated CD8 T cells is essential for their survival.

scientific article published on 24 October 2011

Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells

scientific article published on 01 April 2020

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy

scientific article published on 12 July 2019

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity ⬇️

scientific article published on April 21, 2003

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy.

scientific article published on 19 April 2018

Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels

scientific article published on 23 July 2019

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

scientific article published on 27 July 2018

Contraction of T cell richness in lung cancer brain metastases.

scientific article published in February 2018

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

scientific article

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

scientific article

CpG-induced antitumor immunity requires IL-12 in expansion of effector cells and down-regulation of PD-1.

scientific article published on 2 September 2016

Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth.

scientific article published on 06 June 2013

Functional Expression of Programmed Death-Ligand 1 (B7-H1) by Immune Cells and Tumor Cells

scientific article published on 10 August 2017

Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma.

scientific article published on 25 February 2011

Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

scientific article published on 4 December 2017

NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

scientific article published on 15 December 2021

PD-1 Restrains Radiotherapy-Induced Abscopal Effect.

scientific article

PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy

scientific article published on 30 April 2019

PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells

scientific article published on 17 April 2017

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.

scientific article published on 16 January 2018

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

scientific article published on 06 December 2018

Pokeweed mitogen induces p55 interleukin-2 receptor expression on human monocytes and its effect on interleukin-2 activated monocyte cytotoxicity

scientific article published on 01 December 1992

Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma

scientific article published on 19 February 2019

T cell Bim levels reflect responses to anti-PD-1 cancer therapy.

scientific article published on May 2016

Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy

scientific article published on 18 December 2018

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

scientific article published in Nature Communications

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer

scientific article published on 08 August 2016

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

scientific article

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

scientific article (publication date: August 2002)

Paulina is supported by:

About Paulina

Help